Table 1.
Covariate | Patient cohort (n=53) |
---|---|
Age1 (years) (median (IQR)) | 64 (59 – 69) |
Race/ethnicity (n (%)) | |
White | 44 (83%) |
Asian | 3 (6%) |
Hispanic | 6 (11%) |
Time between diagnostic and 1st targeted biopsy (months) (median (IQR)) | 6 (0 – 8) |
Time between diagnostic and 2nd targeted biopsy (months) (median (IQR)) | 17 (8 – 21) |
Prostate volume1 (cc) (median, IQR) | 48 (36 – 60) |
Prior prostate treatment1 (n (%)) | |
No prior treatment | 37 (69%) |
Transurethral resection of prostate | 3 (6%) |
5α-reductase inhibitor | 13 (25%) |
PSA1 (ng/mL) (median, IQR) | 4.3 (2.2 – 6.4) |
PSA density1 (ng/mL/cc) (median, IQR) | 0.08 (0.05 – 0.12) |
At time of biopsy 1